Evidence map›Paper›PMID 37213047›Full record

ArticleGeroScience2023

Unique trans-kingdom microbiome structural and functional signatures predict cognitive decline in older adults.

Diptaraj S Chaudhari, Shalini Jain, Vinod K Yata, Sidharth P Mishra, Ambuj Kumar, Amoy Fraser, Judyta Kociolek, Mariana Dangiolo, Amanda Smith, Adam Golden and 7 more

Open access · hybridAbstract read
In one paragraph

Article in GeroScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Exploring the role of infectious pathogens in Alzheimer's disease neuroinflammation.Frontiers in cellular and infection microbiology · 2026
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Diptaraj S ChaudhariUSF Center for Microbiome Research, Institute for Microbiomes, University of South Florida Morsani College of Medicine, Tampa, FL, 33612, USA.
Shalini JainUSF Center for Microbiome Research, Institute for Microbiomes, University of South Florida Morsani College of Medicine, Tampa, FL, 33612, USA.
Vinod K YataUSF Center for Microbiome Research, Institute for Microbiomes, University of South Florida Morsani College of Medicine, Tampa, FL, 33612, USA.
Sidharth P MishraUSF Center for Microbiome Research, Institute for Microbiomes, University of South Florida Morsani College of Medicine, Tampa, FL, 33612, USA.
Ambuj KumarMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Amoy FraserMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Judyta KociolekMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Mariana DangioloMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Amanda SmithMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Adam GoldenMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Michal M MasternakMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Peter HollandMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Marc AgroninMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Cynthia White-WilliamsMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Andrea Y ArikawaMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Corinne A LabyakMicrobiome in aging Gut and Brain (MiaGB) Consortium Team, FL, Tampa, USA.
Hariom YadavUSF Center for Microbiome Research, Institute for Microbiomes, University of South Florida Morsani College of Medicine, Tampa, FL, 33612, USA. hyadav@usf.edu.ORCID 0000-0003-4504-1597
University of South Florida · USUniversity of Central Florida · USFlorida Atlantic University · USUniversity of North Florida · USUSF Health Byrd Alzheimer's Institute · US

Funding

Repurposing of Metormin for Older Patients with HFpEFU01AG076928 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KITZMAN, DALANE W, YADAV, HARIOM · 2022 to 2024
$2.3M
Gut microbiota-based biomarkers of Alzheimer's disease and its modulation by a ketogenic dietR56AG064075 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI YADAV, HARIOM · 2020 to 2021
$1.2M
Microbial therapy improves gut permeability to reduce cognitive decline and Alzheimer’s diseaseRF1AG071762 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI YADAV, HARIOM · 2021 to 2021
$1.1M
The role of gut microbiota in the efficacy of ketogenic diet to ameliorate Alzheimer's diseaseR21AG072379 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI YADAV, HARIOM · 2021 to 2021
$429k
Metformin and Alzheimer's disease: Underlying Mechanisms that Ameliorate ProgressionR56AG069676 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI YADAV, HARIOM · 2020 to 2020
$388k
NIA NIH HHS R21 AG072379NIA NIH HHS R21AG072379NIA NIH HHS R56 AG064075NIA NIH HHS R56AG064075NIA NIH HHS R56 AG069676NIA NIH HHS R56AG069676NIA NIH HHS RF1 AG071762NIA NIH HHS RF1AG071762NIA NIH HHS U01 AG076928NIA NIH HHS U01AG076928
6 · The paper itself

Abstract

The prevalence of age-related cognitive disorders/dementia is increasing, and effective prevention and treatment interventions are lacking due to an incomplete understanding of aging neuropathophysiology. Emerging evidence suggests that abnormalities in gut microbiome are linked with age-related cognitive decline and getting acceptance as one of the pillars of the Geroscience hypothesis. However, the potential clinical importance of gut microbiome abnormalities in predicting the risk of cognitive decline in older adults is unclear. Till now the majority of clinical studies were done using 16S rRNA sequencing which only accounts for analyzing bacterial abundance, while lacking an understanding of other crucial microbial kingdoms, such as viruses, fungi, archaea, and the functional profiling of the microbiome community. Utilizing data and samples of older adults with mild cognitive impairment (MCI; n = 23) and cognitively healthy controls (n = 25). Our whole-genome metagenomic sequencing revealed that the gut of older adults with MCI harbors a less diverse microbiome with a specific increase in total viruses and a decrease in bacterial abundance compared with controls. The virome, bacteriome, and microbial metabolic signatures were significantly distinct in subjects with MCI versus controls. Selected bacteriome signatures show high predictive potential of cognitive dysfunction than virome signatures while combining virome and metabolic signatures with bacteriome boosts the prediction power. Altogether, the results from our pilot study indicate that trans-kingdom microbiome signatures are significantly distinct in MCI gut compared with controls and may have utility for predicting the risk of developing cognitive decline and dementia- debilitating public health problems in older adults.

Indexed as

Cognitive DysfunctionDementiaMicrobiotaAgedBacteriaHumansPilot ProjectsRNA, Ribosomal, 16SRNA, Ribosomal, 16SAgingCognitive impairmentGut-brain axisGut microbiomeMiaGBShotgun metagenomics

Identifiers

PMID37213047
PMCPMC10643725
OpenAlexW4377221298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.